Cargando…
Micafungin versus caspofungin in the treatment of Candida glabrata infection: a case report
BACKGROUND: Micafungin and caspofungin, which are both echinocandins, elicit their antifungal effects by suppressing the synthesis of β-D-glucan, an essential component of fungal cell walls. If micafungin is not effective against a fungal infection, is it unreasonable to switch to caspofungin? CASE...
Autores principales: | Yamada, Shoko Merrit, Tomita, Yusuke, Yamaguchi, Tomotsugu, Matsuki, Toshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100314/ https://www.ncbi.nlm.nih.gov/pubmed/27821139 http://dx.doi.org/10.1186/s13256-016-1096-z |
Ejemplares similares
-
Limitations of caspofungin in the treatment of obstructive pyonephrosis due to Candida glabrata infection
por: Schelenz, Silke, et al.
Publicado: (2006) -
Micafungin Is an Efficient Treatment of Multi Drug-Resistant Candida glabrata Urosepsis: A Case Report
por: Javorova Rihova, Zuzana, et al.
Publicado: (2021) -
Cellular apoptosis: An alternative mechanism of action for caspofungin against Candida glabrata
por: Aryamloo, Parisa, et al.
Publicado: (2019) -
A case of Candida glabrata severe urinary sepsis successfully treated with micafungin
por: Pieralli, Filippo, et al.
Publicado: (2014) -
A case of breakthrough Candida parapsilosis fungemia during micafungin therapy for a Candida glabrata bloodstream infection
por: Norimatsu, Yuta, et al.
Publicado: (2017)